nav-left cat-right
cat-right

GPC Biotech and Ingenium receive joint drug discov...

GPC Biotech, a public company, is primarily focused on the research and development of cancer drugs. Ingenium is a private company focused on the treatment of pain. The collaboration sees both companies working towards establishing proof of concept for the activity of specific kinase inhibitors using animal models, and will cover several disease areas. The goal is to rapidly advance novel drug targets towards clinical...

Protagen AG installs new management and board of d...

Dortmund (April 14, 2005) – Protagen closed a first financing round with the VC S-VentureCapital Dortmund for the expansion of its protein biochip business. In the course of this capital influx, positions in the management and the board of directors have been reorganized. Dr. Stefan Muellner has taken over the position of the CSO in the board of Protagen AG. Dr. Muellner brings a lot of experience from positions in...

Trigen and ProCorde Merge to Create Europe’s...

Complete pipeline of novel, competitive, clinical-stage products addressing major in-hospital and out-patient thrombosis markets — Extensive portfolio of pre-clinical and discovery-stage programmes and platforms targeting cardiovascular diseases — Complementary expertise with resulting competences in discovery, development and commercialisation of small molecules and protein therapeutics —...

LifePharms, Inc., Sloan-Kettering Institute, RTI I...

Groton, CT, New York, NY, and Research Triangle Park, NC.: April 7, 2005 – – As part of an effort to strengthen our nation’s bio-defenses against an outbreak of smallpox, LifePharms, Inc., the Sloan-Kettering Institute of Memorial Sloan-Kettering Cancer Center and The Natural Products Laboratory of RTI International have received a 5-year, $5 million research grant from the National Institute of Allergy...

Cottonseed Drug Boosts Cancer Treatment in Mice

Gossypol, a drug refined from cottonseed oil, and previously tried and abandoned as a male contraceptive, could boost the effectiveness of treatment for prostate cancer and possibly other common cancers as well. New York /PSA Rising/ October 5, 2004 — Gossypol, a drug made from a toxic yellow pigment in cottonseed, for about a decade has been tested for use against prostate and other cancers. Gossypol in cotton is a...

Dr. Chris Lipinski (TB Alliance) Honored by Americ...

Dr. Chris Lipinski (TB Alliance) Honored by American Chemical Society for Rule of Five Dr. Christopher Lipinski, member of the TB Alliance Scientific Advisory Committee and a retired Senior Research Fellow at Pfizer Global R&D Groton New London labs, has been honored for his groundbreaking “Rule of Five” by the American Chemical Society. On August 23rd, the ACS announced that Dr. Lipinski is the recipient of...

The inhibitory effects of gossypol on human prosta...

Laboratory of Reproductive and Molecular Endocrinology, College of Veterinary Medicine, The Ohio State University, 1900 Coffey Road, Columbus, OH 43210, USA. BACKGROUND: Racemic gossypol [(+/-)-GP], a naturally occurring polyphenolic yellow pigment present in cottonseed products, inhibits in vitro proliferation of Dunning prostate cancer cells (MAT-LyLu), human prostate cancer cells derived from a bone marrow metastasis...

BIOMOL and TimTec establish a collaboration to cre...

lymouth Meeting, PA, June 26, 2002 – BIOMOL Research Laboratories, Inc. and TimTec Corporation have announced a collaboration to provide the drug discovery research community with comprehensive chemical [diversity] libraries. BIOMOL will design and market this series of products. TimTec brings access to a vast selection of small molecules – both synthetic and derived from nature. TimTec will be responsible for...

Producer-funded: Research would boost cottonseed u...

“We’re 80 percent of the way there, but that’s not enough. Our research is continuing in Texas, Oklahoma, and California.” Cottonseed may one day offer increased returns as a result of research efforts by Cotton Incorporated, says Bill Lalor, vice president of research for the producer-funded research/promotion organization. “Most growers and ginners don’t see the very extensive marketing...

Inhibition of human prostate cancer cells growth b...

Laboratory of Reproductive and Molecular Endocrinology, College of Veterinary Medicine, Ohio State University, Columbus 43210-1092, USA. Gossypol (GP), an antifertility agent in males, is also capable of inhibiting the proliferation of a wide range of cancer cells in vivo and in vitro. Thus, in this study we investigated the effect of GP on the growth of human androgen-independent prostate cancer cell line (PC3). The results...
Page 139 of 139« First...102030...135136137138139